Mechanistically, CES2 promotes lipid oxidation to reverse hepatic steatosis and dissociates activation of ER stress, as well as the downstream effector proteins IKK and JNK, from inflammation, Akt activation, and glucose intolerance. Here, AKT1 is linked to fatty liver disease.